Abstract | BACKGROUND: METHODS: Age-matched 12- to 15-week-old normotensive rats [male Wistar Kyoto (WKY)] and spontaneously hypertensive rats (SHR) were used. Propofol (10 mg kg(-1), 10-50 mg kg(-1) h(-1) i.v.) was administered and the mesenteric microcirculation (<70 µm) observed with fluorescent in vivo microscopy using fluorescein isothiocyanate-conjugated bovine serum albumin (100 mg kg(-1) i.v.). Western blotting was used to measure tissue expression of the α(1C) LTCC subtype. Pressure myography was used to assess isolated mesenteric arterioles (<350 µm) in response to BAYK8644 (0.1 nM-1 µM), a specific LTCC channel agonist. RESULTS:
Propofol dilated isolated arterioles {336.6 µM [mean (sd) change 16.2 (5.8)%]}. However, constriction to BAYK8644 was reduced at this concentration of propofol [EC(50)=8.3 (0.1) log mol(-1)] compared with controls [7.4 (0.1) log mol(-1), P<0.05], suggesting that propofol inhibited LTCCs. The sensitivity of LTCCs increased during hypertension, as in vivo there was a greater increase in mean arterial pressure (MAP) to BAYK8644 [10 µg kg(-1), WKY: 59.5 (9.3)%; SHR: 97.7 (6.3)%, P<0.05] with exaggerated constriction of arterioles [10 µg kg(-1), WKY: 9.1 (2.5)%; SHR: 19.1 (2.6)%, P<0.05]. Propofol also decreased MAP in SHR over time (P<0.05), but remained unchanged in WKY. Using western blotting, expression of α(1C) was greater in SHR compared with WKY (P<0.05). CONCLUSIONS:
Propofol acts via LTCC channels, with increased channel expression and sensitivity in genetically hypertensive rats. We suggest that increased sensitivity and expression of LTCCs may be a mechanism for exaggerated hypertension during propofol anaesthesia.
|
Authors | B K Lawton, N J Brown, C S Reilly, Z L S Brookes |
Journal | British journal of anaesthesia
(Br J Anaesth)
Vol. 108
Issue 6
Pg. 929-35
(Jun 2012)
ISSN: 1471-6771 [Electronic] England |
PMID | 22511481
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anesthetics, Intravenous
- Calcium Channel Blockers
- Calcium Channels, L-Type
- 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
- Propofol
|
Topics |
- 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
(pharmacology)
- Anesthetics, Intravenous
(pharmacology)
- Animals
- Blood Pressure
(drug effects)
- Calcium Channel Blockers
(pharmacology)
- Calcium Channels, L-Type
(drug effects, physiology)
- Dose-Response Relationship, Drug
- Hypertension
(physiopathology)
- Male
- Microvessels
(drug effects, physiology)
- Propofol
(pharmacology)
- Rats
- Rats, Inbred SHR
- Rats, Inbred WKY
- Splanchnic Circulation
(drug effects)
|